| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/14/2008 | US20080193964 Compositions and methods for regulation of calcium-dependent signaling in brain |
| 08/14/2008 | US20080193949 Using selectin concentration as diagnostic indicator of thrombosis |
| 08/14/2008 | US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders |
| 08/14/2008 | US20080193589 Rehydration composition |
| 08/14/2008 | US20080193561 For oral administering; mixture of polyunsaturated fatty acid, phospholipids, controller of methionine metabolism such as folic acid, vitamins, minerals, zinc |
| 08/14/2008 | US20080193462 Inhibiting tumor cell growth in subject by administering to said subject a combination of a cytotoxic or a chemotherapeutic agent and a composition comprising an insulin-like growth factor receptor-1 (IGF-1R) inhibitor; demonstrating specific approaches to enhance therapeutic window of IGF-1R inhibition |
| 08/14/2008 | US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies |
| 08/14/2008 | US20080193437 Two oligonucleotides each containing 2'-deoxy-7-deazaguanosine and linked by a non-nucleotide linker and where the sequences are at least partially self-complementary; anticarcinogenic agents; antiinflammatory agents; autoimmune diseases; antiallergens asthma; disease; gene therapy; vertabrates |
| 08/14/2008 | US20080193426 Increasing homing of CD34 by administering chemokines, fusion protein; irradiation, cyclophosphamide or 5-fluorouracil; interleukins; Gaucher disease |
| 08/14/2008 | US20080193425 Methods for administering fgf18 |
| 08/14/2008 | US20080193383 administering delta receptor angonists such as diarylmethyl piperazine and diarylmethyl piperidine compounds; side effect reduction of anesthetics, barbiturates and analgesics |
| 08/14/2008 | CA2677354A1 Progesterone for the treatment or prevention of spontaneous preterm birth |
| 08/13/2008 | EP1956093A1 von Willebrand Factor (vWF)-cleaving protease |
| 08/13/2008 | EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/13/2008 | EP1955708A1 Novel memory ctl induction potentiator |
| 08/13/2008 | EP1955707A1 Pharmaceutical composition for prevention or treatment of neurogenic pain |
| 08/13/2008 | EP1955703A1 Viruses for the treatment of cellular proliferative disorders |
| 08/13/2008 | EP1955700A2 Therapeutic treatment of androgen receptor driven conditions |
| 08/13/2008 | EP1955696A2 Use of EDG receptor binding agents in cancer |
| 08/13/2008 | EP1954316A1 Methods of treating anxiety disorders |
| 08/13/2008 | EP1954315A2 Use of oligouronates for treating mucus hyperviscosity |
| 08/13/2008 | EP1954314A2 Preparation, comprising iron(iii) complex compounds and redox-active substances |
| 08/13/2008 | EP1954313A1 Treatment of obesity and related disorders |
| 08/13/2008 | EP1954262A2 Compositions for regulating metabolic disorders and methods of use thereof |
| 08/13/2008 | EP1954257A2 Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion |
| 08/13/2008 | EP1954256A2 Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent |
| 08/13/2008 | EP1635850B1 Antimicrobial silver comprising silver |
| 08/13/2008 | EP1501566B1 Medical products comprising a haemocompatible coating, production and use thereof |
| 08/13/2008 | EP1476200A4 Compositions and method for regulation of calcium-dependent signalling in brain |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1427379B1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 08/13/2008 | EP1421946B1 A pharmaceutical composition for treating hiv infection |
| 08/13/2008 | EP1401378B1 A prepreg, a composite and their uses |
| 08/13/2008 | EP1389098B1 Delivery of antipsychotics through an inhalation route |
| 08/13/2008 | EP1389097B1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 08/13/2008 | EP1359931A4 Prevention of diabetes by administration of gnrh antagonists |
| 08/13/2008 | EP1313415B1 Devices for intraocular drug delivery |
| 08/13/2008 | EP1214453B1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 08/13/2008 | EP1213028B1 Hm1.24 antigen expression potentiators |
| 08/13/2008 | EP1137773B1 Growth factor homolog zvegf3 |
| 08/13/2008 | EP1117736B2 Modified starch film compositions |
| 08/13/2008 | EP1082029B1 Sitostanol formulation with emulsifier to reduce cholesterol absorption |
| 08/13/2008 | EP0647137B1 Glycine receptor antagonists and the use thereof |
| 08/13/2008 | CN101243074A Heterocyclic compounds |
| 08/13/2008 | CN101242837A Synergistic modulation of FLT3 kinase using aminopyrimidines kinase modulators and a farnesyl transferase inhibitor |
| 08/13/2008 | CN101242829A Pharmaceutical composition comprising PPAR regulator |
| 08/13/2008 | CN101242826A Combination therapy using AZD2171 and platinum anti-tumor agent |
| 08/13/2008 | CN101241127A Sgk and Nedd used as diagnostic and therapeutic targets |
| 08/13/2008 | CN101240149A Self penetration-promoting pressure-sensitive adhesive containing alcoholic acid oligomer and application thereof |
| 08/13/2008 | CN101239216A Novel sacculus dilating catheter |
| 08/13/2008 | CN101239186A Use of soluble lymphotoxin-beta receptors |
| 08/13/2008 | CN101239185A Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredient |
| 08/13/2008 | CN101239090A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101239089A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101239069A Application of compound capable of supplying active methyl or engaging in methyl migration |
| 08/13/2008 | CN101239062A Use of 5-HT5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 08/13/2008 | CN100410388C Method for identifying compound of increasing bone mineral substance density |
| 08/13/2008 | CN100410275C Novel anti-igf-ir antibodies and uses thereof |
| 08/13/2008 | CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 08/13/2008 | CN100409896C Senile dementia vaccinum and preparing method thereof |
| 08/13/2008 | CN100409847C Transdermal delivery system for alkaloids of aconitum species |
| 08/13/2008 | CN100409845C Association and medicinal composition of CB1 receptor antagonist and application in preparing medicament for treating obesity |
| 08/13/2008 | CN100409841C Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 08/13/2008 | CN100409840C Application of inhibitors of glycogen synthase kinase-3 betta in preparing medicament for increasing bone formation |
| 08/12/2008 | US7411076 such as 2-chloro-N-(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)benzamide, used for intensifying the effects of cancer therapy based on DNA injury; protein kinase inhibitors; side effect reduction |
| 08/12/2008 | US7411043 Slo4 potassium channel proteins |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/12/2008 | US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders |
| 08/12/2008 | US7410983 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 08/12/2008 | US7410979 Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections |
| 08/12/2008 | US7410955 Therapeutic use of agonist ligands specific to G2A receptor |
| 08/12/2008 | US7410777 Continously induced g-protein coupled receptors; membrane binding assays |
| 08/12/2008 | US7410774 Compounds modulating sister chromatid separation and method for identifying same |
| 08/12/2008 | US7410759 Compositions and methods for diagnosing and treating mood disorders |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | US7410639 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 08/12/2008 | CA2396156C Osmotic device containing venlafaxine and an anti-psychotic agent |
| 08/12/2008 | CA2320224C Method for modulating macrophage activation |
| 08/12/2008 | CA2256582C Oxa acids and related compounds for treating skin conditions |
| 08/12/2008 | CA2184828C Composition for inactivating irritants in fluids |
| 08/09/2008 | CA2618099A1 Antagonists of a non-selective cation channel in neural cells |
| 08/07/2008 | WO2008095093A2 Method of increasing cellular function and health of glutathione deficient animals |
| 08/07/2008 | WO2008094969A2 Combination therapy with angiogenesis inhibitors |
| 08/07/2008 | WO2008094737A2 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 08/07/2008 | WO2008094484A2 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors |
| 08/07/2008 | WO2008093827A1 Therapeutic agent for central nervous system disorder, and method for treatment of central nervous system disorder |
| 08/07/2008 | WO2008093691A1 Protective agent for retinal nerve or optic nerve |
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008093194A1 Cannabinoid receptor modulators for treating non-immediate type allergic diseases |
| 08/07/2008 | WO2008093072A2 Topical composition against contact dermatitis due to water |
| 08/07/2008 | WO2008092796A1 Antitumor combination comprising a morpholinyl anthracycline and an antibody |
| 08/07/2008 | WO2008054639A3 Use of a catechin or polyphenol to treat ocular diseases and infection |
| 08/07/2008 | WO2007143002A3 Nutraceutical treatments for diabetic and non-diabetic wound healing |
| 08/07/2008 | WO2007069274A3 Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent |
| 08/07/2008 | US20080188573 Use of thy1-fp transgenic mouse for the identification of ophthalmic agents |
| 08/07/2008 | US20080188550 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |